Foliamenthoic acidCAS# 26187-80-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 26187-80-4 | SDF | Download SDF |
| PubChem ID | 12681385 | Appearance | Oil |
| Formula | C10H16O3 | M.Wt | 184.2 |
| Type of Compound | Monoterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2E,6E)-8-hydroxy-2,6-dimethylocta-2,6-dienoic acid | ||
| SMILES | CC(=CCO)CCC=C(C)C(=O)O | ||
| Standard InChIKey | SMFMBDDFGPDMMD-RFSWUZDDSA-N | ||
| Standard InChI | InChI=1S/C10H16O3/c1-8(6-7-11)4-3-5-9(2)10(12)13/h5-6,11H,3-4,7H2,1-2H3,(H,12,13)/b8-6+,9-5+ | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Foliamenthoic acid shows α-glucosidase inhibition. |
Foliamenthoic acid Dilution Calculator
Foliamenthoic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 5.4289 mL | 27.1444 mL | 54.2888 mL | 108.5776 mL | 135.722 mL |
| 5 mM | 1.0858 mL | 5.4289 mL | 10.8578 mL | 21.7155 mL | 27.1444 mL |
| 10 mM | 0.5429 mL | 2.7144 mL | 5.4289 mL | 10.8578 mL | 13.5722 mL |
| 50 mM | 0.1086 mL | 0.5429 mL | 1.0858 mL | 2.1716 mL | 2.7144 mL |
| 100 mM | 0.0543 mL | 0.2714 mL | 0.5429 mL | 1.0858 mL | 1.3572 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 6-Prenylsakuranetin
Catalog No.:BCN7883
CAS No.:261776-61-8
- 6-Methyl-8-prenylnaringenin
Catalog No.:BCN6860
CAS No.:261776-60-7
- 3,19-Dihydroxy-6,23-dioxo-12-ursen-28-oic acid
Catalog No.:BCN1471
CAS No.:261768-88-1
- Beesioside Q
Catalog No.:BCC8301
CAS No.:261767-91-3
- Denudatine
Catalog No.:BCN5406
CAS No.:26166-37-0
- CGS 35066
Catalog No.:BCC5916
CAS No.:261619-50-5
- Naproxen Sodium
Catalog No.:BCC6490
CAS No.:26159-34-2
- 3,5-Dihydroxybenzaldehyde
Catalog No.:BCN2257
CAS No.:26153-38-8
- Linderene acetate
Catalog No.:BCN8042
CAS No.:26146-28-1
- Linderene
Catalog No.:BCN2779
CAS No.:26146-27-0
- MB05032
Catalog No.:BCC1731
CAS No.:261365-11-1
- Antiarol rutinoside
Catalog No.:BCN5137
CAS No.:261351-23-9
- SB269970 HCl
Catalog No.:BCC5056
CAS No.:261901-57-9
- Isotaxiresinol
Catalog No.:BCN4660
CAS No.:26194-57-0
- CALP2
Catalog No.:BCC5898
CAS No.:261969-04-4
- CALP3
Catalog No.:BCC5900
CAS No.:261969-05-5
- Cl-HOBt
Catalog No.:BCC2829
CAS No.:26198-19-6
- 3alpha-Acetoxy-20-oxo-29-norlupane-23,28-dioic acid
Catalog No.:BCN6507
CAS No.:262272-76-4
- 3,6-Dihydroxy-1,7-dimethoxyxanthone
Catalog No.:BCN6394
CAS No.:262292-34-2
- H-D-Aib-OH
Catalog No.:BCC3151
CAS No.:2623-91-8
- Debenzoylgalloylpaeoniflorin
Catalog No.:BCC8927
CAS No.:262350-51-6
- Mudanpioside J
Catalog No.:BCC9050
CAS No.:262350-52-7
- Torcetrapib
Catalog No.:BCC2330
CAS No.:262352-17-0
- 7,15-Dihydroxypodocarp-8(14)-en-13-one
Catalog No.:BCN1470
CAS No.:262355-96-4
Phytochemical and Pharmacological Investigations on Nymphoides indica Leaf Extracts.[Pubmed:27282639]
Phytother Res. 2016 Oct;30(10):1624-1633.
Nymphoides indica (L.) Kuntze (Menyanthaceae) is traditionally used in the Indian subcontinent. However, scientific data reporting its constituents are poor. This study aimed at evaluating its phytochemical constituents and various biological activities. Phytochemical investigations of the extracts and fractions resulted in the isolation of 5 lipophilic compounds, i.e. azelaic (nonanedioic) acid (1) and 4-methyl-heptanedioic acid (3), hexadecanoic (2) and stearic acid (5) and the fatty alcohol hexadecanol (4); 3 seco-iridoids, i.e. 7-epiexaltoside (6), 6'',7''-dihydro-7-epiexaltoside (7) and menthiafolin (8); 3 flavonoids, i.e. 3,7-di-O-methylquercetin-4'-O-beta-glucoside (9), 3-O-methylquercetin-7-O-beta-glucoside (10) and 3,7-di-O-methylquercetin (11); scopoletin (12) and ferulic acid (13); and the monoterpenoids Foliamenthoic acid (14) and 6,7-dihydroFoliamenthoic acid methyl ester (15). Compounds 1-5 showed moderate antimicrobial activities, whereas compound 9 presented mild antiprotozoal activities against Trypanosoma brucei (IC50 8 muM), Leishmania infantum (IC50 32 muM) and Trypanosoma cruzi (IC50 30 muM). Antiglycation activity was shown by compounds 7 (IC50 0.36 mM), 10 (IC50 0.42 mM) and 15 (IC50 0.61 mM). Finally alpha-glucosidase inhibition was shown by compounds 7, 9, 11 and 13-15. It could be concluded that N. indica leaf extracts possess mild to moderate antimicrobial, antiprotozoal, antioxidant and antidiabetic activities. Copyright (c) 2016 John Wiley & Sons, Ltd.
